P06.13?A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncology
P06.11 Classification of high-grade glioma using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry imaging (MALDI MSI): interim results of the GLIOMIC study. Neuro Oncology
Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One
Andrea Botticelli1, Marina Borro2, Concetta Elisa Onesti3, Lidia Strigari4, Giovanna Gentile5, Bruna Cerbelli6, Adriana Romiti1, Mario Occhipinti3, Claudia Sebastiani5, Luana Lionetto5, Luca Marchetti7, Maurizio Simmaco2, Paolo Marchetti1,3,5, Federica Mazzuca1,3 1Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy 2Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), “Sapienza” University of Rome, Rome, […]
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of Translational Medicine
Giorgia Gurioli1†, Samanta Salvi1†, Filippo Martignano1, Flavia Foca2, Roberta Gunelli3, Matteo Costantini4, Giacomo Cicchetti5, Ugo De Giorgi6, Persio Dello Sbarba7, Daniele Calistri1 and Valentina Casadio1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS 2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura […]
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist
Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study. APMIS
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer
Andrea Casadei Gardini1, Elisa Chiadini2, Luca Faloppi3, Giorgia Marisi2, Angelo Delmonte1, Mario Scartozzi4, Cristian Loretelli3, Alessandro Lucchesi1, Devil Oboldi5, Alessandra Dubini6, Giovanni Luca Frassineti1 and Paola Ulivi2 1Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS 2Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori […]